SU403183A1 - METHOD OF OBTAINING DERIVATIVE TETRAHYDROBENZODIAZEPINONA - Google Patents
METHOD OF OBTAINING DERIVATIVE TETRAHYDROBENZODIAZEPINONAInfo
- Publication number
- SU403183A1 SU403183A1 SU1445809A SU1445809A SU403183A1 SU 403183 A1 SU403183 A1 SU 403183A1 SU 1445809 A SU1445809 A SU 1445809A SU 1445809 A SU1445809 A SU 1445809A SU 403183 A1 SU403183 A1 SU 403183A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- carbon atoms
- nitro
- hydrogen atom
- substituted
- group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- QPLDLSVMHZLSFG-UHFFFAOYSA-N copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims description 4
- 238000006254 arylation reaction Methods 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- -1 alkali metal acetic acid salt Chemical class 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 6
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 239000005751 Copper oxide Substances 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 238000007796 conventional method Methods 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 150000001879 copper Chemical class 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 229910000431 copper oxide Inorganic materials 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000007530 organic bases Chemical class 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- QARVLSVVCXYDNA-UHFFFAOYSA-N Bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M Copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M Potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- IJCWFKHKIKRUAR-UHFFFAOYSA-N 1,2,4,5-tetrahydro-1,2-benzodiazepin-3-one Chemical class N1NC(=O)CCC2=CC=CC=C21 IJCWFKHKIKRUAR-UHFFFAOYSA-N 0.000 description 1
- FOYWCEUVVIHJKD-UHFFFAOYSA-N 2-methyl-5-(1H-pyrazol-5-yl)pyridine Chemical compound C1=NC(C)=CC=C1C1=CC=NN1 FOYWCEUVVIHJKD-UHFFFAOYSA-N 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 241001397173 Kali <angiosperm> Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Description
Изобретение относитс к способу иолучени новых производных тетрагидробензодиазепииона , обладающих ценными фармакологическими свойствами.This invention relates to a process for the preparation of new tetrahydrobenzodiazepionic derivatives with valuable pharmacological properties.
Основанный на известной реакции N-арилировани или N-гетероарилировани гетероциклических соединений, иредлагаемый способ позвол ет получить новые соединени , обладающие больщей активностью, чем известные соединени подобиого действи .Based on the known reaction of N-arylation or N-heteroarylation of heterocyclic compounds, and the proposed method allows to obtain new compounds with greater activity than the known compounds of similar effect.
Предлагаетс способ получени производных тетрагидробензодиазепинона общей формулы IA method for the preparation of tetrahydrobenzodiazepinone derivatives of general formula I is proposed.
жении галоидом, нитро- или трифторметильной группой;halogen, nitro or trifluoromethyl group;
Кз - атом водорода, галоид, оксн-, трифторметил- , нитро- или цианогруппа, заключающийс в том, что производное бензодиазенинона общей формулы IIKs is a hydrogen atom, a halogen, oxn-, trifluoromethyl-, nitro, or cyano group, consisting of the benzodiazeninone derivative of the general formula II
li-(LEili- (LEi
СН2CH2
//
N - C I II Kz 0N - C I II Kz 0
15 где RI и Rs имеют приведенные значени ,15 where RI and Rs are given as
подвергают арилированию или гетероарилированию соединением формулы IIIsubjected to arylation or heteroaryl compound of formula III
Rj-XRj-x
растворител , не реагирующего с компонентами реакции, как ксилол.solvent that does not react with the components of the reaction, like xylene.
Соединени формулы II могут быть полуncHFji из соединений формулы IVCompound II
N- СИ N-SI
V. JV. J
ноbut
где радикалы Ri и Ra имеют иазваииое значение , нутем восстановлени его иптрогрупиы сол но кислотой, нричем обычно одновременно нроисходнт замыкание диазенинового кольца. Прн применении других восстановителей , замыкание кольна может быть нроведеио доиолиителыю. Такие соединенн формулы IV, в которых Ra обозначает нитрогрунну, могут быть селективио восстаиовлеиы.where the radicals Ri and Ra have an immense value, the nüeme of restoring its group with a hydrochloric acid, usually at the same time as the initial closure of the diazenin ring. When using other reducing agents, the closure of a pins may be in the liquidity. Such compounds of formula IV, in which Ra is a nitro hormone, can be selectively reduced.
Соединени (|}ормулы I могут образовывать кнслотно-адднтивные солн. Примен юигимис кислотами вл ютс , например, галогеноводородные кислоты, серна и метансульфонова кислоты.The compounds (|} of Formula I can form solar-additive sun). Use of hydhisic acids are, for example, hydrohalic acids, sulfuric and methanesulfonic acids.
Пример 1. 7-Хлор-5-фенил-1Н-2,3,4,5-тетрагидро-1 ,5-беизодиазенин-4-он.Example 1. 7-Chloro-5-phenyl-1H-2,3,4,5-tetrahydro-1, 5-beisodiasenin-4-one.
10 г 7-хлор-1Ы-2,3,4,5-тетрагидро-1,5-бепзодиазенин-4-она вместе с 25 мл бромбензола.10 g of 7-chloro-1Y-2,3,4,5-tetrahydro-1,5-bepzodiazenin-4-one along with 25 ml of bromobenzene.
50 мл пиридина, 10 г медного порошка, 1 г хлорида меди (I) и 10 г ацетата кали в течение 6 час нагревают в автоклаве до температуры 160°С. Затем отсасывают через кизельгур , промывают метиленхлоридом, выпаривают в вакууме, добавл ют 50 мл концентрироваииого аммиака и извлекают экстракцией метиленхлоридом. Фильтрат сушат иад сульфатом магни , упаривают в вакууме, очищают активированным углем, кристаллизуют из смеси метиленхлорида и изопропилового эфира. Выход 3,5 г (61%), т. пл. 166-168°С, т. пл. гидрохлорида 158-161°С.50 ml of pyridine, 10 g of copper powder, 1 g of copper (I) chloride and 10 g of potassium acetate are heated in an autoclave to a temperature of 160 ° C for 6 hours. It is then suction filtered through kieselgur, washed with methylene chloride, evaporated in vacuo, 50 ml of concentrated ammonia are added and the mixture is extracted with methylene chloride. The filtrate is dried with magnesium sulfate, evaporated in vacuo, purified with activated carbon, crystallized from a mixture of methylene chloride and isopropyl ether. The yield of 3.5 g (61%), so pl. 166-168 ° C, so pl. hydrochloride 158-161 ° C.
Пример 2. 7-бром-1-оксиэтил-5-фенил-1Н2 ,3,4,5-тетрагидро-1,5-бензодиазеиин-4-он.Example 2. 7-bromo-1-hydroxyethyl-5-phenyl-1H2, 3,4,5-tetrahydro-1,5-benzodiazine-4-one.
6 г 7-бром-1-оксиэтил-1П-2,3,4,5-тетрагидро1 ,5-бензодиазепин-4-она, сильно размешива , кип т т с 20 мл бромбензола, 20 мл диэтилеидигликоль-диметилэфира , 6 г ацетата кали ,6 g of 7-bromo-1-hydroxyethyl-1P-2,3,4,5-tetrahydro1, 5-benzodiazepin-4-one, while stirring vigorously, are boiled with 20 ml of bromobenzene, 20 ml of diethylideglycol dimethyl ether, 6 g of acetate Kali,
1 г хлорида меди (I) и 6 г окиси меди (II) в течение 3 час.1 g of copper (I) chloride and 6 g of copper (II) oxide for 3 hours.
После окончани реакции добавл ют уголь, отсасывают в гор чем состо нии через кизельгур , повторно промывают метилеихлоридом,After completion of the reaction, coal is added, sucked off in a hot state through kieselguhr, repeatedly washed with methylene chloride,
сгущают в вакууме и перекристаллизовывают из метанола. Выход 3,4 г (51%), т. пл. 153- 154°С.concentrated in vacuo and recrystallized from methanol. The output of 3.4 g (51%), so pl. 153-154 ° C.
Соответствешю приведенным примерам были получены следуюнд,ие соединеии , указан 1ые в таблице.Corresponding to the given examples were obtained the following, and the compounds are listed first in the table.
Предмет изобретени Subject invention
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19691929656 DE1929656A1 (en) | 1969-06-11 | 1969-06-11 | Tetrahydro-1,5-benzodiazepine-4-ones |
DE19702006600 DE2006600A1 (en) | 1970-02-13 | 1970-02-13 | Tetrahydro-1,5-benzodiazepine-4-ones |
Publications (3)
Publication Number | Publication Date |
---|---|
SU399135A1 SU399135A1 (en) | |
SU403183A1 true SU403183A1 (en) | |
SU403183A3 SU403183A3 (en) | 1973-10-19 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU218488B (en) | New process for producing imidazo-pyridine derivatives | |
GODEFROI et al. | The Preparation of Some Derivatives of β-(10-Phenothiazinyl) propionic Acid and β-(2-Chloro-10-phenothiazinyl) propionic Acid | |
JPS62192377A (en) | Manufacture of 2-(imidazolin-2-yl)-3-pyridine-or -3-quinolinecarboxylic acid | |
SU481155A3 (en) | Production method - (furyl-methyl) morphinans | |
CA2368815A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
SU403183A1 (en) | METHOD OF OBTAINING DERIVATIVE TETRAHYDROBENZODIAZEPINONA | |
WO2018065924A1 (en) | Intermediates of mitogen-activated protein kinase kinase (map2k or mek) inhibitors and process for their preparation | |
TW201802103A (en) | Preparation method of obeticholic acid and intermediates thereof | |
JPS648616B2 (en) | ||
JPH0449539B2 (en) | ||
KR0141482B1 (en) | Process for the preparation of o-carboxypyridyl and o-carboxyquinolylimidazolinones | |
CA2686312A1 (en) | Process for preparing aromatase inhibitors | |
JPH06199759A (en) | Preparation of phenylacetic acid derivative | |
US4958029A (en) | Process for the production of isoindoline derivatives, novel intermediates and process for their production | |
SU493965A3 (en) | The method of obtaining d-2-substituted-6-alkyl-8-substituted ergolin | |
SU449485A3 (en) | The method of obtaining-substituted esters of 1,2,3,6-tetrahydro-4-pyridylmethylcarboxylic acid | |
TWI845992B (en) | A method for preparing a hepatitis B virus nucleocapsid inhibitor | |
US3450709A (en) | Process for the preparation of ring-substituted 2-aminoimidazoles | |
KR930009817B1 (en) | Process for preparation of pyridine derivatives | |
JP2517735B2 (en) | Method for producing 6-hydroxy-3-pyridinecarboxylic acid ester | |
JP3109903B2 (en) | Asymmetric 9-aminostyryl-10-styrylanthracene derivatives and process for producing the same | |
RU2733731C1 (en) | Method of producing intermediate products for synthesis of kalanolides and analogues thereof | |
WO2023006986A1 (en) | Method for preparing and purifying an agent suitable for treating anemia | |
SARGENT | THE SYNTHESIS OF 1-ETHYL-, 2-ETHYL-, 3-ETHYL-AND 4-ETHYL-ACRIDINE1 | |
SU355803A1 (en) |